BIONIC links the natural product NP329 to yeast cell-wall biogenesis and β-1,6-glucan synthesis
The BIONIC graph-convolutional network integrated yeast interaction datasets and predicted essential-gene chemical sensitivities to the uncharacterized compound NP329. Experimental screens supported four BIONIC-predicted sensitive genes in the cell-wall biogenesis process; follow-up tests showed related steroidal alkaloid jervine reduced β-1,6-glucan and KRE6/SKN1 mutations conferred resistance, supporting a pathway-level connection for this compound family.
Technology: BIONIC (Biological Network Integration using Convolutions), a graph-convolutional deep-learning network-integration method
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Experimental screens supported four BIONIC-predicted sensitive genes in the cell-wall biogenesis process; follow-up tests showed related steroidal alkaloid jervine reduced β-1,6-glucan and KRE6/SKN1 mutations conferred resistance, supporting a pathway-level connection for this compound family.
- Still unknown: BIONIC predicted chemical–genetic sensitivity, not direct molecular binding. NP329 is pseudojervine; jervine is a related compound tested in follow-up. The authors report jervine reduced β-1,6-glucan and KRE6/SKN1 mutations conferred resistance, implicating but not biochemically proving target engagement. Yeast-specific findings.
- AI role: BIONIC combined yeast protein-interaction, coexpression and genetic-interaction network features to predict essential-gene chemical sensitivities. For NP329 it predicted four of six experimentally sensitive essential genes in the glycosylation/cell-wall biogenesis process, helping identify this cellular process for follow-up. The later jervine experiments are supportive chemical-family follow-up, not direct proof that BIONIC predicted the jervine interaction.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11236286/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 61 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.